Navigation Links
ISTO Technologies Granted Key Patent for Cartilage Cell Expansion by the United States Patent Office
Date:10/1/2007

ST. LOUIS, Oct. 1 /PRNewswire/ -- ISTO Technologies, Inc., a privately held orthobiologics company, today announced that the United States Patent Office granted a key patent protecting the Company's core technology for cell-based cartilage repair: "Method for Chondrocyte Expansion with Phenotype Retention."

Currently, ISTO is developing products for cartilage regeneration and repair in knee joints and spinal discs using its cartilage cell expansion technology. Cartilage cells (chondrocytes) normally lose their native phenotype after serial expansion in vitro, and can no longer produce functional cartilage tissue. To circumvent this problem, ISTO's scientific team has developed a process for growing chondrocytes without the loss of phenotype, thereby providing a commercially viable number of cartilage cells for clinical applications.

"This is a significant patent for the Company. Our cell expansion technology serves as a platform for developing products for wide ranging medical needs," said Mitchell Seyedin, Ph.D., President & Chief Executive Officer, ISTO Technologies, Inc.

Cartilage regeneration is often called the "holy grail" of the orthopaedic industry because of its potential to restore function to damaged joints which otherwise have limited healing potential. Cartilage serves as a "shock absorber" protecting all joints including spinal discs from the wear and tear experienced during motion. Degeneration of cartilage in joints and spinal discs often leads to irreversible damage, causing pain and disability. Two of the most common causes of disability in adults, osteoarthritis and degenerative discs, are joint diseases affecting cartilage of the joints and spinal discs, respectively.

ISTO Technologies, Inc. is an orthobiologics company focusing on the development of differentiated products for sports medicine, spinal therapy and trauma. ISTO's products are intended for the repair and regeneration of damaged or injured cartilage and bone. For additional information, visit ISTO Technologies' website at http://www.istotech.com, or contact the company by phone at (314) 995-6049.


'/>"/>
SOURCE ISTO Technologies, Inc.
Copyright©2007 PR Newswire.
All rights reserved

Related biology technology :

1. Barriers will not stop convergence of medical technologies
2. Merge Technologies net loss doubles to $10.1M
3. Making deals with evolving technologies in mind
4. Third Wave Technologies to raise $14.9M through private debt
5. Meier joins Broadlook Technologies as COO
6. Platypus Technologies secures $450K SBIR grant
7. Napier joins board of Third Wave Technologies
8. aOva Technologies raises $3 million
9. Consumer, business technologies face same challenges
10. Promega to get early access to WARF technologies under new agreement
11. Linda Weber to run Fiservs Interactive Technologies unit
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:12/2/2016)... ... December 02, 2016 , ... ... and biotechnology companies dedicated to collaboratively developing improved chemistry, manufacturing and control ... vendor-supported, portable online UHPLC, with robust, probe-based sampling. , Online liquid ...
(Date:12/2/2016)... --  SurePure, Inc. (OTCQB: SURP) a global leader ... concluded an agreement with Tamarack Biotics under which Tamarack ... acquire units of the Company,s patented photopurification technology with ... Concurrently with the option, SurePure has entered ... seek regulatory approvals in the United States ...
(Date:12/2/2016)... 2, 2016 /PRNewswire/ - bioLytical Laboratories, a world leader in rapid infectious disease tests, ... Pharmaceutical Association members. (Photo: http://photos.prnewswire.com/prnh/20161201/444905 ) ... ... , , ... Pharmaceutical Association (KPA) to introduce the INSTI HIV Self Test to 350 pharmacy representatives ...
(Date:11/30/2016)... , Nov. 30, 2016  GenomOncology today announced the appointment ... of Medical Affairs.  Dr. Coleman will oversee ... company,s proprietary knowledge-enabled platform. The GenomOncology software suite empowers molecular ... sequencing data and clinical decision support, from quality control through ... , , ...
Breaking Biology Technology:
(Date:11/24/2016)... Cercacor today introduced Ember TM Sport ... non-invasively measure hemoglobin, Oxygen Content, Oxygen Saturation, Perfusion ... in approximately 30 seconds. Smaller than a smartphone, using ... to key data about their bodies to help monitor ... Hemoglobin carries oxygen to muscles. When hemoglobin ...
(Date:11/17/2016)... Global Market Watch: Primarily supported by ownership types; ... Academics) market is to witness a value of US$37.1 billion ... Compounded Annual Growth Rate (CAGR) of 10.75% is foreseen from ... 2014-2020. North America is not way ... Europe at 9.56% respectively. Report Focus: ...
(Date:11/14/2016)... Technology, Inc. ("xG" or the "Company") (Nasdaq: XGTI, XGTIW), ... in challenging operating environments, announced its results for the ... a conference call to discuss these results on November ... Key Recent Accomplishments ... acquire Vislink Communication Systems. The purchase is expected to ...
Breaking Biology News(10 mins):